RAINEY GERMAIN: Open Payments
NPI 1073198891 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 22 payments from 13 companies in 2025. Trend: 2023 $218 · 2024 $1,033 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $197 |
| Novo Nordisk Inc | 5 | $105 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Seqirus USA Inc | 1 | $21 |
Products named: FASENRA, AIRSUPRA, Ozempic, TRELEGY ELLIPTA, JARDIANCE, Cologuard Collection Kit, XIFAXAN, Veozah.
Industry payments across TN — which companies pay providers there.
